Is it useful to add peg- ifn in poor responder patients to bulevirtide 2 mg? results from the french multicenter early access programVictor De Ledinghen,Marie-Noelle Hilleret,Sophie Metivier,Louis D'Alteroche,Christiane Stern,Xavier Causse,Si Nafa Si Ahmed,Eric Billaud,Juliette FoucherHEPATOLOGY(2023)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要